Fresenius Medical Care Delivers Robust Organic Growth in Revenue and Income in Q1 2025

Fresenius Medical Care Achieves Strong Start to 2025 with Solid Organic Growth and Improved Profitability Across Segments Fresenius Medical Care, the world’s leading provider of products and services for individuals with chronic kidney failure, began 2025 with a strong operational…

Read MoreFresenius Medical Care Delivers Robust Organic Growth in Revenue and Income in Q1 2025

Modivcare Unveils Leadership Transitions Amid Strategic Evolution of Business Model

Modivcare Announces Executive Leadership Transitions Amid Strategic Business Model Evolution Modivcare Inc. (Nasdaq: MODV), a leading technology-enabled healthcare services company focused on delivering supportive care solutions that address social determinants of health, today announced the planned departures of two key…

Read MoreModivcare Unveils Leadership Transitions Amid Strategic Evolution of Business Model

TAE Life Sciences Partners with Ohio State University to Drive Innovation in Boron-Based Cancer Therapies

TAE Life Sciences and Ohio State Forge Landmark Partnership to Advance Boron-Based Precision Cancer Therapies In a significant leap forward for precision oncology, TAE Life Sciences (TLS), a pioneer in accelerator-based cancer treatment technologies, has announced a transformative collaboration with…

Read MoreTAE Life Sciences Partners with Ohio State University to Drive Innovation in Boron-Based Cancer Therapies

Emmy-Winning Series Unveils Trailer for Shelter Me: The Cancer Pioneers, Highlighting Breakthroughs in Cancer Treatment and Hope

Emmy-Winning Series Unveils Trailer for Shelter Me: The Cancer Pioneers, a Moving Documentary on Dogs Leading the Fight Against Cancer The Emmy Award-winning Shelter Me series has released the official trailer for its newest and most impactful installment yet: Shelter…

Read MoreEmmy-Winning Series Unveils Trailer for Shelter Me: The Cancer Pioneers, Highlighting Breakthroughs in Cancer Treatment and Hope

HAYA Therapeutics to Unveil RNA-Guided Genome Platform at ASGCT Meeting

HAYA Therapeutics to Present Breakthroughs in RNA-Guided Regulatory Genome Platform at 2025 ASGCT Annual Meeting HAYA Therapeutics, SA, a biotechnology company at the forefront of developing precision RNA-guided therapeutics that reprogram pathogenic cell states, announced today its participation at the…

Read MoreHAYA Therapeutics to Unveil RNA-Guided Genome Platform at ASGCT Meeting